The randomized, double-blind, placebo-controlled study, "Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid," compared the effects of a high concentration DHA diet with a standard DHA diet in premature infants born earlier than 33 weeks.
